Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Low Urin Tract Symptoms ; 10(2): 135-142, 2018 May.
Article in English | MEDLINE | ID: mdl-28150436

ABSTRACT

OBJECTIVE: To evaluate the efficacy and safety of gabapentin in comparison to solifenacin succinate and placebo for the treatment of adult patients with overactive bladder (OAB). METHOD: A 12-week, randomized, double-blind, double dummy placebo-controlled, clinical trial was conducted between October 2010 and August 2014 at a tertiary medical center. Eligible and consenting patients included were randomized into three treatment groups (placebo, gabapentin and solifenacin). After a 12-week treatment period, an intention to treat analysis was applied to assess between group differences on the micturitions and urgency episodes per 24 h; which were evaluated by 3-day micturition diary mean change from baseline to post treatment. Health related quality of life (HRQOL) domains were likewise assessed by OAB questionnaire (OAB-q). Adverse event were monitored and summarized. Study results were analyzed at statistical significance of 0.05. (ClinicalTrials.gov ID NCT01486706) RESULT: A total of 94 participants were included for end-study efficacy and safety analysis. Compared to placebo, gabapentin and solifenacin have statistically significant improvement in mean number of micturitions per 24 h (adjusted mean difference [AMD] -1.179, 95%CI -1.98, -0.38; P < 0.001; -1.706, 95%CI -2.52, -0.09; P < 0.001; respectively), and in mean number of urgency episodes per 24 h (AMD -0.903, 95%CI -1.44, -0.37; P < 0.001; -0.896, 95%CI -1.44, -0.35; P < 0.001). Gabapentin also demonstrated significant improvement over the solifenacin in the mean number of nocturia episodes/24 h (AMD -0.607, 95%CI -1.04, -0.18; P < 0.001). Adverse event related to gabapentin treatment was lesser than solifenacin, and comparable to placebo. CONCLUSION: Gabapentin treatment with acceptable safety profile, improves OAB symptoms and HRQOL domains.


Subject(s)
Amines/administration & dosage , Cyclohexanecarboxylic Acids/administration & dosage , Muscarinic Antagonists/administration & dosage , Solifenacin Succinate/administration & dosage , Urinary Bladder, Overactive/drug therapy , Urological Agents/administration & dosage , gamma-Aminobutyric Acid/administration & dosage , Adolescent , Adult , Aged , Amines/adverse effects , Cyclohexanecarboxylic Acids/adverse effects , Double-Blind Method , Drug Administration Schedule , Female , Gabapentin , Humans , Male , Middle Aged , Muscarinic Antagonists/adverse effects , Prospective Studies , Quality of Life , Solifenacin Succinate/adverse effects , Treatment Outcome , Urological Agents/adverse effects , Young Adult , gamma-Aminobutyric Acid/adverse effects
2.
Investig Clin Urol ; 58(6): 468-473, 2017 11.
Article in English | MEDLINE | ID: mdl-29124248

ABSTRACT

Given that both orchidopexy and circumcision are commonly done in a single operative setting, we adopted a technique of combined orchidopexy and circumcision using a single circumcision incision. We applied this new technique to boys with palpable, low inguinal cryptorchidism. Here we describe a case series of 7 boys who underwent concurrent orchidopexy via the circumcision site. We present this novel technique and discuss our preliminary outcomes, including the anatomic basis and feasibility. The technique appears to be an alternative for concurrent circumcision and cryptorchid cases with palpable, low inguinal testes.


Subject(s)
Circumcision, Male , Cryptorchidism/surgery , Orchiopexy/methods , Adolescent , Child , Child, Preschool , Humans , Infant , Inguinal Canal , Male , Palpation , Retrospective Studies , Treatment Outcome
3.
Can Urol Assoc J ; 9(7-8): E463-70, 2015.
Article in English | MEDLINE | ID: mdl-26279717

ABSTRACT

INTRODUCTION: We provide an overview of the quality of recent clinical clinical practice guidelines (CPGs) for non-neurogenic male lower urinary tract symptoms (LUTS) and summarize the recommendations for their diagnosis, assessment, and treatment. METHODS: We systematically searched recent (2008-2013) CPGs for non-neurogenic male LUTS. Eligible CPGs were assessed and appraised using Appraisal of Guidelines, Research and Evaluation II (AGREE II) tool by a CPG-appraisal group. The appraisal scores for each guideline were summarized according to each domain and in total. A recommendation summary was made across the guidelines for diagnostics, conservative management, medical, minimally invasive therapy, and surgical management. RESULTS: A total of 8 guidelines were considered. According to AGREE II appraisal of guidelines, the National Institute for Health and Clinical Excellence (NICE), American Urological Association (AUA) and European Association of Urology (EAU) consistently scored high on the guideline domains assessed. Recommendations on diagnostics, conservative management, medical, and surgical management were consistent among the top 3 guidelines. However, we noted a discrepancy in recommending minimally invasive therapy as an alternative management of moderate to severe or bothersome non-neurogenic male LUTS secondary to benign prostatic enlargement (BPE); the NICE guideline, in particular, does not recommend using minimally invasive therapy. CONCLUSION: The quality of recent CPGs on non-neurogenic male LUTS was appraised and summarized. The guidelines from NICE, AUA and EAU were considered highly compliant to the AGREE II proposition for guideline formation and development.

4.
Prostate Int ; 3(2): 65-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26157771

ABSTRACT

PURPOSE: To determine the prevalence of premature ejaculation (PE) among adult Asian males presented with lower urinary tract symptoms (LUTS) and characterize its association with other clinical factors. METHODS: A cross-sectional study was conducted at a tertiary medical center to determine the prevalence of PE among adult male participants with LUTS during the Annual National Prostate Health Awareness Day. Basic demographic data of the participants were collected. All participants were assessed for the presence and severity of LUTS using the International Prostate Symptom Score (IPSS), and for the presence of PE using the PE diagnostic tool. Digital rectal examination was performed by urologists to obtain prostate size. LUTS was further categorized into severity, storage symptoms (frequency, urgency, and nocturia), and voiding symptoms (weak stream, intermittency, straining, and incomplete emptying) to determine their association with PE. Data were analyzed by comparing the participants with PE (PE diagnostic tool score ≥11) versus those without PE, using the independent t test for continuous data, Mann-Whitney U test for ordinal data, and Chi-square test for nominal data. The statistical significance was set at P < 0.05. RESULTS: A total of 101 male participants with a mean ± standard deviation age of 60.75 ± 10.32 years were included. Among the participants, 33% had moderate LUTS, and 7% severe LUTS. The most common LUTS was nocturia (33%). The overall prevalence of PE was 27%. There was no significant difference among participants with PE versus those without PE in terms of age, marital status, prostate size, or total IPSS score. However, significant difference between groups was noted on the level of education (Mann-Whitney U, z = -1.993, P = 0.046) where high educational status was noted among participants with PE. Likewise, participants with PE were noted to have more prominent weak stream (Mann-Whitney U, z = -2.126, P = 0.033). CONCLUSIONS: Among the participants consulted with LUTS, 27% have concomitant PE. Educational status seems to have an impact in the self-reporting of PE, which may be due to a higher awareness of participants with higher educational attainment. A significant association between PE and weak stream that was not related to prostate size suggests a neuropathologic association.

5.
Asian J Urol ; 2(2): 114-122, 2015 Apr.
Article in English | MEDLINE | ID: mdl-29264129

ABSTRACT

OBJECTIVE: To configure and validate a novel prostate disease nomogram providing prostate biopsy outcome probabilities from a prospective study correlating clinical indicators and diagnostic parameters among Filipino adult male with elevated serum total prostate specific antigen (PSA) level. METHODS: All men with an elevated serum total PSA underwent initial prostate biopsy at our institution from January 2011 to August 2014 were included. Clinical indicators, diagnostic parameters, which include PSA level and PSA-derivatives, were collected as predictive factors for biopsy outcome. Multiple logistic-regression analysis involving a backward elimination selection procedure was used to select independent predictors. A nomogram was developed to calculate the probability of the biopsy outcomes. External validation of the nomogram was performed using separate data set from another center for determination of sensitivity and specificity. A receiver-operating characteristic (ROC) curve was used to assess the accuracy in predicting differential biopsy outcome. RESULTS: Total of 552 patients was included. One hundred and ninety-one (34.6%) patients had benign prostatic hyperplasia, and 165 (29.9%) had chronic prostatitis. The remaining 196 (35.5%) patients had prostate adenocarcinoma. The significant independent variables used to predict biopsy outcome were age, family history of prostate cancer, prior antibiotic intake, PSA level, PSA-density, PSA-velocity, echogenic findings on ultrasound, and DRE status. The areas under the receiver-operating characteristic curve for prostate cancer using PSA alone and the nomogram were 0.688 and 0.804, respectively. CONCLUSION: The nomogram configured based on routinely available clinical parameters, provides high predictive accuracy with good performance characteristics in predicting the prostate biopsy outcome such as presence of prostate cancer, high Gleason prostate cancer, benign prostatic hyperplasia, and chronic prostatitis.

6.
Article in English | WPRIM (Western Pacific) | ID: wpr-632706

ABSTRACT

OBJECTIVE: This study aimed to determine the association between Lower Urinary Tract Symptoms (LUTS) and premature ejaculation and define its prevalence and factors associated among Filipino males during the Annual National Digital Rectal Exam (DRE) day. METHODOLOGY: A descriptive cross sectional study was done in all male participants during the Annual National DRE day conducted at the Institute of Urology, St. Luke's Medical Center-Quezon City. All subjects were assessed by urologists for the presence of LUTS using the International Prostate Symptom Score (IPSS), and the Premature Ejaculation Diagnostic Tool (PEDT). The IPSS was categorized into total score (IPSS sum), storage symptoms (FUN - frequency, urgency, nocturia) and voiding symptoms (WISR - weak stream, intermittency, straining and residual urine). Ultrasound was also performed to obtain prostate size. The relationship between age, demographics, prostate size, IPSS scores, storage symptom score, voiding symptom score, and PEDT scores were analyzed using one way ANOVA. The statistical significance was set at P RESULTS: A total of 101 male participants were included in the study. Participants' age ranged from 36 to 86, with a mean age of 61 ±. The mean IPSS was 5.79 (±6.59 SD). The most common symptom is nocturia with prevalence of 32.7%. The prevalence of PE is 26.7% and 16.8% has probable PE. There are no associations between PE and age, LUTS, storage and voiding symptoms, prostate size and co-morbid illnesses such as hypertension and diabetes showing p values of 0.291, 0.226, 0.600, 0.108, 0.908, 0.954 and 0.833 respectively. However PE was associated with weak stream (P= 0.015) and educational attainment (P=0.008). CONCLUSION: Filipino men are becoming more concern about their health. LUTS are commonly seen in men in increasing age. PE is a very common male sexual dysfunction so there is a need for identification of such patients (17). Although, no correlation has been made between age, LUTS and PE in this study, however in further correlational analysis, educational status seems to have an impact in the self-reporting PE which may be due to higher awareness of participants with higher education. It is recommended that clinicians always utilize the screening questions for PE to give the appropriate treatment, since patients are often unwilling to volunteer their symptoms on PE (4.17). Our study also showed significant correlation with PE and weak stream, without association to prostate size. relating to a possible neurologic physiologic pathway rather than anatomic etiology of PE. Further study is recommended.


Subject(s)
Humans , Male , Aged , Middle Aged , Adult , Ejaculation , Premature Ejaculation , Sexual Dysfunction, Physiological , Lower Urinary Tract Symptoms
7.
Article in English | WPRIM (Western Pacific) | ID: wpr-632634

ABSTRACT

OBJECTIVE: Prostate cancer is the most common cancer in men and localized prostate adenocarcinoma has multiple treatment options. In this study, the objective was to review the outcome of patients that were treated with HDR brachytherapy as monotherapy in all prostate adenocarcinoma patients at the St Luke's Medical Center. MATERIALS AND METHODS: Thirty three (33) patients who underwent HDR prostate brachytherapy as monotherapy for prostate adenocarcinoma in a single institution for the past 5 years received 38 Gy in 4 fractions. The charts of these patients were reviewed to determine biochemical control using the Phoenix criteria and ASTRO definition, and toxicity. RESULTS: Patients showed good biochemical control, with 92.16% meeting the target PSA value of 2 ng/mL or less and a 96.51% without consecutive rise of PSA post brachytherapy. There was also minimal toxicity, with no report of gastrointestinal toxicity and 9.1% rate of temporary genitourinary toxicity. CONCLUSION: Good biochemical control of prostate adenocarcinoma was achieved with the use of HDR brachytherapy as monotherapy, with a minimal toxicity profile.


Subject(s)
Humans , Male , Aged , Middle Aged , Brachytherapy , Adenocarcinoma , Prostate
8.
J Pediatr Surg ; 49(11): 1659-67, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25475814

ABSTRACT

BACKGROUND/PURPOSE: Gonadotropin releasing hormone(GnRH) as an adjunct to orchidopexy for the treatment of cryptorchidism is still controversial. Present evidences were studied through a meta-analysis of comparative clinical trials. METHOD: Systematic literature search was done up to September 30, 2013. Studies were independently appraised by two reviewers. Continuous data of fertility indices were extracted as weighted mean difference (WMD) and standard deviation (SD); while nominal data of fertility indices were extracted as relative risk (RR). Random effects model was used to analyze the pooled effect estimates. Inter-study heterogeneity and publication bias were assessed. PROSPERO Protocol registration (CRD42013004922). RESULTS: Ten eligible studies were included. The pooled effect estimates showed that cryptorchid children treated with GnRH when compared with controls, have significantly increased germ cell per tubule (WMD: 0.35; 95% CI 0.07-0.62, P=0.01) and increased RR to have normal value of germ cell per tubule (RR: 2.86; 95% CI 1.73-4.71, P<0.0001). Inter-study heterogeneity was noted, source identified with subgroup analysis. Publication bias was not evident. No GnRH related adverse events were reported in all studies. CONCLUSION: Evidence suggests that a subset of boys with cryptorchidism may benefit from GnRH as adjunctive to orchidopexy in improving the fertility index. However, future studies are recommended to specifically identify subgroup characteristics of cryptorchidism that will clearly benefit from the treatment.


Subject(s)
Cryptorchidism/drug therapy , Fertility/drug effects , Gonadotropin-Releasing Hormone/therapeutic use , Child , Cryptorchidism/physiopathology , Humans , Male
9.
Urol Ann ; 6(3): 218-23, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25125894

ABSTRACT

OBJECTIVE: The objective of this study is to determine the diagnostic utility of computed tomography (CT)- scout film with an optimal non-contrast helical CT scan Hounsfield unit (HU) in predicting the appearance of urinary calculus in the plain kidneys, ureter, urinary bladder (KUB)-radiograph. METHODS: A prospective cross-sectional study was executed and data were collected from June 2007 to June 2012 at a tertiary hospital. The included subjects were diagnosed to have <10mm urolithiasis with non-contrast helical CT scan and KUB X-ray, which were carried out on the same day. Both KUB radiographs and CT-scout film were read by two qualified radiologists with inter-observer standardization prior to the study. Urolithiasis characteristics such as stone location, CT attenuation value, CT-scout film and KUB radiograph appearance were recorded independently by two observers. Univariate logistic analysis with receiver operating characteristic curve was generated to determine the best cut-off HU value of urolithiases not identified in CT-scout film, but determined radio-opaque in KUB X-ray. Subsequently, its sensitivity, specificity, predictive values and likelihood ratios were calculated. Statistical significance was set at P value of 0.05 or less. RESULTS: Two hundred and three valid cases were included. 73 out of 75 CT-scout film detected urolithiasis were identified on plain radiograph and determined as radio-opaque. The determined best cut off value of HU utilized for prediction of radiographic characteristics was 630HU at which urinary calculi were not seen at CT-scout film and were KUB X-ray radio-opaque. The set HU cut-off was established of ideal accuracy with an overall sensitivity of 82.2%, specificity of 96.9% and a positive predictive value of 96.5% and negative predictive value of 83.5%. CONCLUSION: Urolithiases identified on the CT-scout film were also seen as radiopaque on the KUB radiograph while those stones not visible on the CT-scout film, but above the optimal HU cut-off value of 630 are also likely to be radiopaque.

10.
Prostate Int ; 2(1): 31-6, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24693532

ABSTRACT

PURPOSE: "Mag-paDRE" is a yearly prostate health public awareness program initiated by the Philippine Urological Association. This study aimed to describe the demographic and clinical data of the participants in the 2013 "Mag-paDRE" program and to identify factors that will further improve prostate health public awareness. METHODS: A descriptive cross-sectional study undertaken to collect and assess the demographic data, International Prostate Symptom Score (IPSS) and digital rectal examination findings of the participants in the "Mag-paDRE" conducted in the 10 Philippine Board of Urology (PBU) different accredited training institutions. Descriptive statistics was used to report the proportion of Filipino men aged 40 or older who presented for their first prostate health evaluation. Clinical profile were reviewed and summarized. The study protocol was registered in the Clinicaltrial.gov under Identifier NCT01886547. RESULTS: A total of 925 participants from the 10 PBU accredited training institutions were assessed. Among the 10 training institutions the large tertiary government owned medical center had the highest number of participants and target participants recruited; while the private sectors owned tertiary hospitals have the highest proportion of target participants and cases. According to the predetermined definition of this study, 614 (66%) were considered the target population for the "Mag-paDRE" program. The mean age of the target participants was 58.9±9.9. Only 360 of 614 (59%) were new case, 118 (32.7%) had severe lower urinary tract symptoms (LUTS), 223 (62%) had moderate LUTS, 19 (5.3%) were asymptomatic but with hard prostates, palpable prostate nodules or prostate tenderness. The most bothersome symptoms were incomplete bladder emptying (30.2%), and frequency (22.9%). CONCLUSIONS: Overall, the 2013 "Mag-paDRE" among the 10 training institutions was effective in promoting prostate health awareness. A need to modify the preactivity information dissemination by these institutions can be done to further increase the attendance of targeted population of the prostate health awareness program.

11.
Can Urol Assoc J ; 7(5-6): E333-43, 2013.
Article in English | MEDLINE | ID: mdl-23766835

ABSTRACT

OBJECTIVE: Our objective was to systematically analyze the evidence for an association between serum level long chain omega-3 polyunsaturated fatty acid (n-3 PUFA) and prostate cancer risk from human epidemiological studies. STUDY PROCEDURES: We searched biomedical literature databases up to November 2011 and included epidemiological studies with description of long chain n-3 PUFA and incidence of prostate cancer in humans. Critical appraisal was done by two independent reviewers. Data were pooled using the general variance-based method with random-effects model; effect estimates were expressed as risk ratio with 95% confidence interval (CI). Heterogeneity was assessed by Chi(2) and quantified by I(2), publication bias was also determined. RESULTS: In total, 12 studies were included. Significant negative association was noted between high serum level of n-3 PUFA doc-osapentaenoic acid (DPA) and total prostate cancer risk (RR:0.756; 95% CI 0.599, 0.955; p = 0.019). Likewise, a positive association between high blood level of fish oil contents, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and high-grade prostate tumour incidence (RR:1.381; 95% CI 1.050, 1.817; p = 0.021) was noted; however, this finding was evident only after adjustment was done on interstudy variability through the removal of a lower quality study from the pool. CONCLUSIONS: High serum levels of long chain n-3 PUFA DPA is associated with reduced total prostate cancer risk. While high blood level of EPA and DHA is possibly associated with increased high-grade prostate tumour risk.

12.
BMC Cancer ; 13: 254, 2013 May 22.
Article in English | MEDLINE | ID: mdl-23697613

ABSTRACT

BACKGROUND: High serum carcinoembryonic antigen (CEA) levels are an independent prognostic factor for recurrence and survival in patients with non-small cell lung cancer (NSCLC). Its role as a predictive marker of treatment response has not been widely characterized. METHODS: 180 patients with advanced NSCLC (stage IIIB or Stage IV), who had an elevated CEA serum level (>10 ng/ml) at baseline and who had no more than one previous chemotherapy regimen, were included. CEA levels were measured after two treatment cycles of platinum based chemotherapy (93%) or a tyrosine kinase inhibitor (7%). We evaluate the change in serum CEA levels and the association with response measured by RECIST criteria. RESULTS: After two chemotherapy cycles, the patients who achieved an objective response (OR, 28.3%) had a reduction of CEA levels of 55.6% (95%CI [box drawings light horizontal]64.3 to [box drawings light horizontal]46.8) compared to its basal level, with an area under the ROC curve (AURC) of 0.945 (95%CI 0.91-0.99), and a sensitivity and specificity of 90.2 and 89.9%, respectively, for a CEA reduction of ≥14%. Patients that achieved a decrease in CEA levels ≥14% presented an overall response in 78% of cases, stable disease in 20.3% and progression in 1.7%, while patients that did not attain a reduction ≥14% had an overall response of 4.1%, stable disease of 63.6% and progression of 32.2% (p < 0.001). Patients with stable (49.4%) and progressive disease (22.2%) had an increase of CEA levels of 9.4% (95%CI 1.5-17.3) and 87.5% (95%CI 60.9-114) from baseline, respectively (p < 0.001). The AURC for progressive disease was 0.911 (95%CI 0.86-0.961), with sensitivity and specificity of 85 and 15%, respectively, for a CEA increase of ≥18%. PFS was longer in patients with a ≥14% reduction in CEA (8.7 vs. 5.1 months, p < 0.001). Neither reduction of CEA nor OR were predictive of OS. CONCLUSIONS: A CEA level reduction is a sensitive and specific marker of OR, as well as a sensitive indicator for progression to chemotherapy in patients with advanced NSCLC who had an elevated CEA at baseline and had received no more than one chemotherapy regimen. A 14% decrease in CEA levels is associated with a better PFS.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoembryonic Antigen/blood , Carcinoma, Non-Small-Cell Lung/blood , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/blood , Lung Neoplasms/drug therapy , Aged , Biomarkers, Tumor , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , Disease Progression , Female , Humans , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging , Prognosis , Prospective Studies , ROC Curve , Risk Factors , Treatment Outcome
13.
Prostate Cancer ; 2013: 875615, 2013.
Article in English | MEDLINE | ID: mdl-23589776

ABSTRACT

Previous researches involving dietary methods have shown conflicting findings. Authors sought to assess the association of prostate cancer risk with blood levels of omega-3 polyunsaturated fatty acids (n-3 PUFA) through a meta-analysis of human epidemiological studies in available online databases (July, 2012). After critical appraisal by two independent reviewers, Newcastle-Ottawa Quality Assessment Scale (NOQAS) was used to grade the studies. Six case control and six nested case control studies were included. Results showed nonsignificant association of overall effect estimates with total or advanced prostate cancer or high-grade tumor. High blood level of alpha-linolenic acid (ALA) had nonsignificant positive association with total prostate cancer risk. High blood level of docosapentaenoic acid (DPA) had significant negative association with total prostate cancer risk. Specific n-3 PUFA in fish oil, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) had positive association with high-grade prostate tumor risk only after adjustment of interstudy variability. There is evidence that high blood level of DPA that is linked with reduced total prostate cancer risk and elevated blood levels of fish oils, EPA, and DHA is associated with high-grade prostate tumor, but careful interpretation is needed due to intricate details involved in prostate carcinogenesis and N-3 PUFA metabolism.

14.
Urolithiasis ; 41(2): 143-51, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23503876

ABSTRACT

The aim of this study is to investigate the efficacy of terpene compound drug (pinene, camphene, borneol, anethole, fenchone and cineol in olive oil) in facilitating spontaneous passage of ureteral calculi through meta-analysis of randomized controlled trials (RCT). Systematic literature search on MEDLINE, EMBASE, OVID, Science Direct, Proquest, Google scholar, Cochrane Library databases and reference list of related literatures were done without language restriction. RCTs on ureterolithiasis medical expulsive therapy (MET) that compare terpene compound drug versus placebo/control group or alpha-blockers were identified. Articles retrieved were critically appraised by two independent reviewers according to Cochrane Collaboration recommendations. Data from included studies were extracted for calculation of risk ratio (RR) and 95 % confidence interval (CI). Effect estimates were pooled using Mantel-Haenszel method with random effect model. Inter-study heterogeneity and publication bias were assessed. The PRISMA guidelines for meta-analysis reporting were followed. Five RCTs (total of 344 subjects) of adequate methodological quality were included. Pooled effect estimates from homogenous studies showed that compared to placebo/control group, patients treated with terpene compound drug had significantly better ureteral calculi spontaneous expulsion rate (pooled RR: 1.34; 95 % CI 1.12, 1.61). Subgroup analysis of studies that compare terpene compound drug with alpha-blockers showed no significant difference (pooled RR: 0.79; 95 % CI 0.59, 1.06), while significant inter-study heterogeneity was noted. Only minor gastrointestinal adverse effect was reported on terpene compound drug use. The results suggest that terpene compound drug as MET is effective in augmenting spontaneous passage of ureterolithiasis. High quality large-scale RCTs comparing alpha-blockers and terpene compound drug are warranted to make a more definitive conclusion.


Subject(s)
Terpenes/therapeutic use , Ureteral Calculi/drug therapy , Adrenergic alpha-Antagonists/therapeutic use , Humans , Randomized Controlled Trials as Topic , Terpenes/administration & dosage , Terpenes/adverse effects , Treatment Outcome
15.
Can Urol Assoc J ; 6(5): 386-92, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23093634

ABSTRACT

Polyurethane, due to its low cost, high versatility and availability, it commonly used for ureteral stents. Spontaneous fracture of these stents is rare, and the most dreaded complication. We present four cases of spontaneous fracture of indwelling polyurethane ureteral stents and review the literature to identify potential factors and preventive strategies.

16.
Rev Med Inst Mex Seguro Soc ; 50(5): 493-5, 2012.
Article in Spanish | MEDLINE | ID: mdl-23282261

ABSTRACT

OBJECTIVE: to determine the distribution of HCV genotypes in a group of HCV infected patients in Mexicali, Mexico. METHODS: a retrospective study which included 66 HCV-infected patients was done. Anti-HCV antibodies were measured by ELISA and were confirmed by the detection of viral RNA in the serum. Subsequently, HCV RNA positive patients were genotyped. Viral loads were compared and risk factors also were investigated. RESULTS: 59 % were women. HCV genotypes found were 1, 2, 3, 4 and mixed. The most frequent subtypes were 1a y 1b (70 %), followed by 3a (12 %), 2b (11 %), mixed (6 %), and 4a (1.5 %). There was no statistically difference significant in medians of viral loads between males/females (p = 0.53). Ten patients had been intravenous drug users; 7 from them resulted with subtype 1a. The most frequent risk factor was blood transfusion (75 %). CONCLUSIONS: the distribution of HCV genotypes in our hospital was similar as those previously reported in other geographic regions of our country.


Subject(s)
Hepacivirus/genetics , Hepatitis C/virology , Adult , Aged , Female , Genotype , Humans , Male , Middle Aged , Retrospective Studies
17.
Article in English | WPRIM (Western Pacific) | ID: wpr-632588

ABSTRACT

OBJECTIVE: To investigate the efficacy of terpene compound drug (pinene, camphene, borneol, anethole, fenchone and cineol in olive oil) in facilitating spontaneous passage of ureteral calculiMETHODS: Systematic literature search of the MEDLINE, EMBASE, OVID, Science Direct, Proquest, Google scholar, Cochrane Library databases and rference lists of related literature was done without language restriction. Trials on ureterolithiasis medical expulsive therapy (MET) that compare terpene compound drug versus placebo/control group or alpha-blockers were identified. Articles retrieved were critically appraised by two independent reviewers according to Cochrane Collaboration recommendations. Data from included studies were extracted for calculation of risk ratio (RR) and 95% confidence interval (CI). Effect estimates were pooled using Mantel-Haenszel method with random effect model. Inter-study heterogeneity and publication bias were assessed. The PRISMA guidelines for meta-analysis reporting were followed.RESULTS: Five trials (total of 344 subjects) of adequate methodological quality were included. Pooled effect estimates from homogenous studies showed that compared to placebo/ control group, patients treated with terpene compound drug had significantly higher ureteral calculi expulsion rate (pooled RR: 1.34; 95% CI 1.12, 1.61). Analysis of studies that compare terpene compound drug with alpha-blockers showed no significant difference (pooled RR: 0.79; 95% CI 0.59, 1.06), although significant inter-study heterogeneity was noted. Only minor gastrointestinal adverse effect was reported on terpene compound drug use.CONCLUSIONS: The results suggest that terpene compound drug as MET is effective in promoting passage of ureterolithiasis. High quality large-scale RCTs comparing alpha-blockers and terpene compound drug are warranted to make a more definitive conclusion.


Subject(s)
Humans , Male , Female , Urologic Diseases , Ureteral Diseases , Ureteral Calculi
18.
Appl Opt ; 48(25): 4826-31, 2009 Sep 01.
Article in English | MEDLINE | ID: mdl-19724323

ABSTRACT

The diffraction patterns of a conical lens illuminated by plane and spherical waves have been intensively investigated. A practical method is described to transform the Bessel profile of a zero-order Bessel beam into a caustic one through the use of a combination of a conical lens and a cylindrical lens, which in turn transforms the field generated by the conical lens. The cylindrical lens was illuminated by a zero-order Bessel beam, producing a lips caustic beam. It is shown that this type of wave tends to regenerate during propagation, although the waves are severely perturbed.

19.
Appl Opt ; 46(34): 8284-90, 2007 Dec 01.
Article in English | MEDLINE | ID: mdl-18059670

ABSTRACT

It is well known that Bessel beams and the other families of propagation-invariant optical fields have the property of self-healing when obstructed by an opaque object. Here it is shown that there exists another kind of field distribution that can have an analog property. In particular, we demonstrate that a class of caustic wave fields, whose transverse intensity patterns change on propagation, when perturbed by an opaque object can reappear at a further plane as if they had not been obstructed. The physics of the phenomenon is fully explained and shown to be related to that of self-healing propagation invariant optical fields.

SELECTION OF CITATIONS
SEARCH DETAIL
...